SIRT3 and hepatocellular carcinoma: Furthermore, mito-IP assay using the anti-SIRT3 antibody showed that mito-COX-2/p-Drp1Ser616 interaction was reduced in RSV-treated HCC cells and correlated with increased SIRT3 (Figure 8B).